Makale detayı · 2023 · article
Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıIntensive care medicine
- Katalog eşleşmesi (ISSN)Intensive Care Medicine
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
PURPOSE: The incidence, patient features, risk factors and outcomes of surgery-associated postoperative acute kidney injury (PO-AKI) across different countries and health care systems is unclear. METHODS: We conducted an international prospective, observational, multi-center study in 30 countries in patients undergoing major surgery (> 2-h duration and postoperative intensive care unit (ICU) or high dependency unit admission). The primary endpoint was the occurrence of PO-AKI within 72 h of surgery defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary endpoints included PO-AKI severity and duration, use of renal replacement therapy (RRT), mortality, and ICU and hospital length of stay. RESULTS: We studied 10,568 patients and 1945 (18.4%) developed PO-AKI (1236 (63.5%) KDIGO stage 1500 (25.7%) KDIGO stage 2209 (10.7%) KDIGO stage 3). In 33.8% PO-AKI was persistent, and 170/1945 (8.7%) of patients with PO-AKI received RRT in the ICU. Patients with PO-AKI had greater ICU (6.3% vs. 0.7%) and hospital (8.6% vs. 1.4%) mortality, and longer ICU (median 2 (Q1-Q3, 1-3) days vs. 3 (Q1-Q3, 1-6) days) and hospital length of stay (median 14 (Q1-Q3, 9-24) days vs. 10 (Q1-Q3, 7-17) days). Risk factors for PO-AKI included older age, comorbidities (hypertension, diabetes, chronic kidney disease), type, duration and urgency of surgery as well as intraoperative vasopressors, and aminoglycosides administration. CONCLUSION: In a comprehensive multinational study, approximately one in five patients develop PO-AKI after major surgery. Increasing severity of PO-AKI is associated with a progressive increase in adverse outcomes. Our findings indicate that PO-AKI represents a significant burden for health care worldwide.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
165atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 32 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.Atıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS‑AKI trialAtıf 29 · OpenAlex
- 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex